Delhi High Court Temporarily Restrains MDL Herbal From Using “HAJMOLA” Mark In Dispute With Dabur

The Delhi High Court on 8 July granted an ex-parte ad-interim injunction in favour of Dabur India Limited and restrained the proprietor of MDL Herbal Dhanvanatri Ayurvedic Mahamritunjay from using the mark “HAJMOLA” or any deceptively similar mark.

Justice Anup Jairam Bhambhani held that Dabur had established a prima facie case of trademark infringement and passing off. He observed:

“In the opinion of this court, the plaintiff has made-out a prima facie case in its favour and against the defendant. Furthermore, considering the facts obtaining in the matter, the balance of convenience also lies in favour of the plaintiff and irreparable harm and injury would result to the plaintiff if the interim relief sought is not granted.”

Dabur approached the Court seeking to restrain the defendant from manufacturing, marketing or selling Ayurvedic digestive tablets under the mark “HAJMOLA” or any deceptively similar mark. It contended that “HAJMOLA” was its prior, well-known and registered trademark.

Accordingly, the Court restrained the defendant from using the mark “HAJMOLA” or any deceptively similar mark, device, logo, domain name or trade name in relation to Ayurvedic digestive tablets or any other goods and services until the next date of hearing.

The matter is listed before the Joint Registrar on 5 October 2026 for completion of pleadings.